Dr.RAKSHA RAO, R17558
Purpose: To evaluate the outcomes of enucleation by the myoconjunctival technique using silicone implant in patients with retinoblastoma.
Methods: Retrospective study.
Results: Of 186 patients, 3 underwent bilateral enucleation (189 eyes). The mean age was 2.3y (5m-11y). Indications were advanced retinoblastoma (n=111, 59%), recurrent disease (n=70, 37%), and orbital extension (n=8, 4%). The average size of the silicone implant used was 19mm (17-20mm). Adjuvant chemotherapy was necessary in 44 (23%), and 14 (7%) required radiotherapy. There was wound infection, extrusion or implant migration. At an average follow-up of 29 months (6m-51m), all patients had satisfactory static and dynamic cosmesis.
Conclusion: Patients with retinoblastoma undergo enucleation at a young age, and may require adjuvant chemotherapy and radiotherapy. Enucleation by the myoconjunctival technique using silicone implant is an excellent technique to prevent wound dehiscence and provide good cosmesis.
PRESENTATION NOT RECEIVED FROM THE AUTHOR.
Leave a Comment